Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Hui‐Ting Li"'
Autor:
Qi‐Le Shen, Qin‐Hua Zhao, Hui‐Ting Li, Jie Deng, Jing He, Lan Wang, Su‐Gang Gong, Jin‐Ming Liu
Publikováno v:
Health Science Reports, Vol 7, Iss 11, Pp n/a-n/a (2024)
Abstract Background and Aims This study aimed to evaluate the hemodynamic alterations and right heart remodeling dynamics in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) undergoing treatment with balloon pulmonary an
Externí odkaz:
https://doaj.org/article/24dc10db56894be287bcdec0fd608efc
Autor:
Shang Wang, Yi Yan, Jian Zhang, Ping Yuan, Ci‐Jun Luo, Hong‐Ling Qiu, Hui‐Ting Li, Jian Xu, Lan Wang, Tian‐Lan Li, Rong Jiang
Publikováno v:
Animal Models and Experimental Medicine, Vol 7, Iss 1, Pp 56-70 (2024)
Abstract Background The maintenance dosage of selexipag is categorized as low, medium or high. In order to assess the efficacy and safety of different dosages of selexipag for the risk stratification of pulmonary arterial hypertension (PAH), we perfo
Externí odkaz:
https://doaj.org/article/0f1bb5ecdead47848e841cb6c581dd2b
Autor:
Wei-Jie Xu, Shang Wang, Qian-Hao Zhao, Jia-Yi Xu, Xiao-Yi Hu, Su-Gang Gong, Jing He, Hong-Ling Qiu, Ci-Jun Luo, Jian Xu, Hui-Ting Li, Ze-Pu Li, Lan Wang, Yu Shi, Ya-Lin Zhao, Rong Jiang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundThis study aimed to employ plasma proteomics to investigate the molecular changes, pathway alterations, and potential novel biochemical markers associated with balloon pulmonary angioplasty (BPA) in patients with chronic thromboembolic pulm
Externí odkaz:
https://doaj.org/article/ae4dc1893e2e49a88b94be6e28819c90
Publikováno v:
Molecules, Vol 29, Iss 2, p 332 (2024)
Thirty-eight new 4-amino-3,5-dicholo-6-(1H-indazolyl)-2-picolinic acids and 4-amino-3,5-dicholo-6-(2H-indazolyl)-2-picolinic acids were designed by scaffold hopping and synthesized to discover potential herbicidal molecules. All the new compounds wer
Externí odkaz:
https://doaj.org/article/11c6d35671574c11aeac2c8314102355
Autor:
Hui-Ting Li, Fang Tan, Tian-Hua Zhang, Long-Hui Cao, Hong-Ying Tan, Wen-Qian Lin, Wei-An Zeng, Xin-Jin Chi
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Curcumin has attracted much attention due to its wide range of therapeutic effects. In this study, we used serum collected from patients undergoing one-lung ventilation (OLV) to establish an in vitro acute lung injury (ALI) model
Externí odkaz:
https://doaj.org/article/e1b5c165d8ae44519d27ca8388c0baac
Autor:
Xiu-Jun Zhong, Rong Jiang, Lu Yang, Ping Yuan, Su-Gang Gong, Qin-Hua Zhao, Ci-Jun Luo, Hong-Ling Qiu, Hui-Ting Li, Rui Zhang, Jing He, Lan Wang, Jie Tang, Jin-Ming Liu
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Pulmonary hypertension in left heart disease (PH-LHD), which includes combined post- and precapillary PH (Cpc-PH) and isolated postcapillary PH (Ipc-PH), differs significantly in prognosis. We aimed to assess whether cardiopulmona
Externí odkaz:
https://doaj.org/article/d31b1ecfbafb463e816083876b5629f3
Autor:
Yu-Yang Liu, Yi-Yang Qu, Shang Wang, Ci-Jun Luo, Hong-Ling Qiu, Hui-Ting Li, Ping Yuan, Lan Wang, Jin-Ling Li, Rong Jiang, Rui Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/c0df077a79ba4e109448c19b7b4900d0
Autor:
Yu-Yang Liu, Yi-Yang Qu, Shang Wang, Ci-Jun Luo, Hong-Ling Qiu, Hui-Ting Li, Ping Yuan, Lan Wang, Jin-Ling Li, Rong Jiang, Rui Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Pulmonary arterial hypertension (PAH) is a rare and progressive disease. Some patients treated with phosphodiesterase type 5 inhibitors (PDE-5is) fail to reach treatment goals. As a novel soluble guanylate cyclase agonist, riociguat act
Externí odkaz:
https://doaj.org/article/85d7fa6cc28f45a5860b43c74fb0191d
Autor:
Qin-Hua Zhao, Su-Gang Gong, Jing He, Ping Yuan, Wen-Hui Wu, Ci-Jun Luo, Rong Jiang, Rui Zhang, Hong-Ling Qiu, Hui-Ting Li, Yuan Li, Jin-Ming Liu, Lan Wang
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-7 (2021)
Abstract Background Management of inoperable chronic thromboembolic pulmonary hypertension (CTEPH) remains a clinical challenge. Currently, riociguat, a soluble guanylate-cyclase stimulator is recommended by international guidelines. More recently, b
Externí odkaz:
https://doaj.org/article/79cb40013f634c76956e1ebeb61bd0df
Autor:
Shang Wang, Zi-Yan Guo, Xing-Xing Sun, Ping Yuan, Qin-Hua Zhao, Wen-Hui Wu, Hong-Ling Qiu, Ci-Jun Luo, Su-Gang Gong, Hui-Ting Li, Rui Zhang, Jing He, Lan Wang, Jin-Ming Liu, Jian Guo, Rong Jiang
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
ObjectiveWhether exercise-induced venous-to-systemic shunt (EIS) during cardiopulmonary exercise testing (CPET) has different manifestations or characteristics in idiopathic pulmonary arterial hypertension (IPAH) and chronic thromboembolic pulmonary
Externí odkaz:
https://doaj.org/article/a94a85a4898642ccb4a30158b73d8bd3